IRCT2013031212419N2招募中3 期
Clinical trial of recovery rate comparison in patients with unexplained chronic cough in the two groups receiving oral cetirizine with and without inhaled budesonide.
The budget will be funded by researchers.0 个研究点目标入组 68 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 68
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •age over 18 years; unexplained chronic cough for more than 8 weeks; absence of underling cardiac diseases; do not using smoking and drugs; absence of clinical and para-clinical asthma evidence; normal chest x-ray; normal spirometry; absence of eosinophilic bronchitis (sputum eosinophil percentage less than 3%); negative (normal) inhaled methacholine provocation test; signed written consent; absence of pregnancy and breast feeding; did not taking steroids during the last 3 months; do not receive any treatment for chronic cough before and during study; do not taking Angiotensin converting enzyme inhibitors (ACEI).
- •Exclusion criteria: dissatisfaction to continuing cooperation in each stage of the study; exacerbation or other accidents which requiring treatment; lack of returning within 48 hours of the deadline for second visit.
排除标准
- 未提供
研究者
相似试验
尚未招募
4 期
A study comparing recovery features of patients undergoing general anaesthesia with rocuronium as muscle relaxant and recieving sugammadex or neostigmine and glycopyrollate for reversal.CTRI/2024/04/065600Manipal Hospital
进行中（未招募）
1 期
Evaluation of the complete remission rates in patients with symptomatic non-erosive reflux disease (NERD) or erosive gastroesophageal reflux disease (GERD) treated with pantoprazole 40 mg o.d. over 4 or 8 or 12 weeks - Complete RemissionGastroesophageal reflux diseaseMedDRA version: 5.0Level: lltClassification code 10038263EUCTR2004-004806-25-HUALTANA Pharma AG
进行中（未招募）
不适用
Evaluation of the complete remission rates in patients with symptomatic non-erosive reflux disease (NERD) or erosive gastroesophageal reflux disease (GERD) treated with pantoprazole 40 mg o.d. over 4 or 8 or 12 weeks - Complete RemissioGastroesophageal reflux diseaseMedDRA version: 5.0Level: lltClassification code 10038263EUCTR2004-004806-25-DEALTANA Pharma AG1,200
进行中（未招募）
不适用
Evaluation of the complete remission rates in patients with symptomatic non-erosive reflux disease (NERD) or erosive gastroesophageal reflux disease (GERD) treated with pantoprazole 40 mg o.d. over 4 or 8 or 12 weeks - Complete RemissioGastroesophageal reflux diseaseMedDRA version: 5.0Level: lltClassification code 10038263EUCTR2004-004806-25-ATALTANA Pharma AG1,200
招募中
2 期
The effect of mucopexy surgical method on the incidence of postoperative complications.Condition 1: Grade 3 and 4 Hemorrhoids, Doppler Guided Hemorrhoidal Artery Ligation, Mucopexy with DG-HAL, Mucopexy without DG-HAL, General Surgery, Colorectal Surgery, Anorectal Diseases. Condition 2: Grade 3 and 4 Hemorrhoids, Mucopexy with DG-HAL, Mucopexy without DG-HAL, General Surgery, Colorectal Surgery, Anorectal Diseases.Hemorrhoids and perianal venous thrombosisFourth degree hemorrhoidsK64.3IRCT20190927044897N1Iran University of Medical Sciences36